Skip to main content
. 2011 Mar 25;31(2):141–147. doi: 10.1007/s10840-011-9556-2

Table 2.

Antiarrhythmic medications

Subject number Age, years Pre-ablation VPC frequency VPC/24 h Post-ablation VPC frequency VPC/24 h Antiarrhythmic drugs used prior to ablation Antiarrhythmic drugs used after ablation Duration of antiarrhythmic drugs after ablation (months) Follow-up (months)
1 52 14,524 4,658 Amiodarone and metoprolol Amiodarone 7 53
2 8 12,457 9,854 Amiodarone Amiodarone 7 45
3 48 9,586 3,567 Amiodarone and metoprolol Amiodarone 8 44
4 44 25,463 11,287 Amiodarone Amiodarone 6 38
5 58 4,502 2,146 Amiodarone and metoprolol Amiodarone 7 37
6 32 3,589 118 Amiodarone and metoprolol Amiodarone 7 33
7 56 12,456 5,478 Amiodarone and metoprolol Amiodarone 7 34
8 49 9,845 2,458 Amiodarone Amiodarone 6 28
9 60 2,589 452 Amiodarone Amiodarone 6 24
10 48 11,244 245 Amiodarone and metoprolol Amiodarone 6 16
11 33 8,574 1,142 Amiodarone Amiodarone 6 13
12 36 1,554 1,283 Amiodarone Amiodarone 7 11
13 20 15,789 8,457 Amiodarone and metoprolol Amiodarone 6 7
14 34 1,145 1,352 Amiodarone and metoprolol Amiodarone 6 6
15 39 8,569 3,478 Amiodarone Amiodarone 3 3

VPC ventricular premature complexes